Upcoming Webinars Archived Webinars Training Vitals Host A Webinar About Get Updates Contact

US Government Launches Microbiome Research Initiative



Researchers have been increasingly identifying links between the microbiome and chronic diseases, including diabetes, asthma and obesity.

Share this!

May 16, 2016 | by Sarah Massey, M.Sc.

On Friday, the White House announced it would be funding a new public-private microbiome research fund, aimed at supporting the development of new therapies promoting healthy bacterial communities. The National Microbiome Initiative (NMI), will be overseen by the Science and Technology Policy group, along with other federal agencies and private companies.

The goal of the initiative is to “foster the integrated study of microbiomes across different ecosystems.” The NMI will be launched with over $121 million in funding for its first year of microbiome studies in human health and agriculture.

Microbiomes are composed of a variety of microorganisms which live in the body, the soil, the oceans, and even the atmosphere. They play a vital role in maintaining the health of humans, animals and the environment.

Researchers have been increasingly identifying links between the microbiome and chronic diseases, including diabetes, asthma and obesity. A better understanding of these microbial communities could lead to the development of new microbiome-targeted medicines.

“The NMI aims to advance understanding of microbiome behavior and enable protection and restoration of healthy microbiome function,” said a statement released by the White House. “In a year-long fact-finding process, scientists from Federal agencies, academia, and the private sector converged on three recommended areas of focus for microbiome science, which are now the goals of the NMI.”

The current goals of the project include developing platform technologies, supporting interdisciplinary research and expanding the workforce of the microbiome project. The Department of Energy, the National Institutes of Health (NIH) and the National Science Foundation are all chipping in to support the initiative.

Keywords: Microbiome, Chronic Disease, NIH


Share this with your colleagues!

Researchers Identify Role of ApoE4 Gene as Possible Drug Target in Alzheimer’s Disease

September 21, 2017 - A team of neurology researchers at Washington University School of Medicine in St. Louis have found that in the presence of the ApoE4 protein, another protein known as tau forms tangles in the brain which contributes to neuronal damage characteristic of Alzheimer’s disease.

Featured In: Life Science News

New Guidelines Address CAR-T Immunotherapy Toxicities to Prevent Patient Deaths

September 20, 2017 - Clinicians at The University of Texas MD Anderson Cancer Center have published new guidelines in the journal, Nature Reviews Clinical Oncology, which could help in the management of these toxicities.

Featured In: Biotech News, Drug Safety News

Microneedle Skin Patch Could Treat Common Metabolic Disorders

September 19, 2017 - Researchers at Columbia University Medical Center (CUMC) and the University of North Carolina have developed a microneedle skin patch impregnated with a drug capable of converting white fat into calorie-burning brown fat.

Featured In: Medical Device News


Five Reasons Why Toronto is Emerging as a Major Life Sciences Hub


Development and Manufacture of Highly Potent API Drug Products Throughout the Clinical Phases

Innovation through Integration – Providing Next Generation Biomedical Devices and Interconnects

Clinical Payments Case Studies: Improving Efficiency, Cash Management, and Compliance

Why Phase 3 Trials Fail: Oncology Case Studies and Lessons Learned

Copyright © 2016-2017 Honeycomb Worldwide Inc.